Antibody Citations
OriGene products have been used extensively by scientists worldwide to improve their research efficiency. For your reference, we have collected a representation of citations for selected OriGene products and posted them at this site.
Search citations by gene symbols or target names
Here are some of the recent papers making use of OriGene products by fellow researchers.
| Target | Research Paper | Journal | Product | SKU |
|---|---|---|---|---|
| ALDH1A3 | Establishment of MAGEC2-knockout cells and functional investigation of MAGEC2 in tumor cells | Cancer Sci, 2016 Dec | Antibody | TA502841S |
| ALDH1A3 | Establishment of MAGEC2-knockout cells and functional investigation of MAGEC2 in tumor cells | Cancer Sci, 2016 Dec | Antibody | TA502805 |
| ALDH1A3 | Establishment of MAGEC2-knockout cells and functional investigation of MAGEC2 in tumor cells | Cancer Sci, 2016 Dec | Antibody | TA502841 |
| ALDH1A3 | ALDH+/CD44+ cells in breast cancer are associated with worse prognosis and poor clinical outcome | Experimental and Molecular Pathology Feb2016, 2016 Feb | Antibody | TA502805 |
| ALDH1A3 | ALDH+/CD44+ cells in breast cancer are associated with worse prognosis and poor clinical outcome | Experimental and Molecular Pathology Feb2016, 2016 Feb | Antibody | TA502805S |
| ALDH1A3 | The Expression of Aldehyde Dehydrogenase Family in Breast Cancer | Journal of Breast Cancer, 2014 Mar | Antibody | TA502805 |
| ALDH1L1 | Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys | PLoS ONE, 2019 Mar | Antibody | TA501869 |
| ALDH1L1 | Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys | PLoS ONE, 2019 Mar | Antibody | TA501869S |
| ALDH1L1 | Targeting Mitochondrial Oxidative Phosphorylation Abrogated Irinotecan Resistance in NSCLC | Sci Rep, 2018 Oct | Antibody | UM500039 |
| ALDH2 | ALDH2 Activity Reduces Mitochondrial Oxygen Reserve Capacity in Endothelial Cells and Induces Senescence Properties | Oxidative Medicine and Cellular Longevity, 2018 Nov | Antibody | TA500615 |
| ALDH2 | ALDH2 Activity Reduces Mitochondrial Oxygen Reserve Capacity in Endothelial Cells and Induces Senescence Properties | Oxidative Medicine and Cellular Longevity, 2018 Nov | Antibody | TA500615S |
| ALDH2 | Calcium Channels and Oxidative Stress Mediate a Synergistic Disruption of Tight Junctions by Ethanol and Acetaldehyde in Caco-2 Cell Monolayers | Sci Rep, 2016 Dec | Antibody | TA324332 |
| ALDH2 | A Novel Mechanism for Endogenous Formaldehyde Elevation in SAMP8 Mouse | J. Alzheimers Dis., 2014 Feb | Antibody | TA500615S |
| ALDH2 | A Novel Mechanism for Endogenous Formaldehyde Elevation in SAMP8 Mouse | J. Alzheimers Dis., 2014 Feb | Antibody | TA500615 |
| ALDH3A1 | Chemoproteomics-Enabled Covalent Ligand Screening Reveals ALDH3A1 as a Lung Cancer Therapy Target | ACS Chem. Biol., 2018 Jul | Antibody | TA501105 |
| ALDH3A1 | Chemoproteomics-Enabled Covalent Ligand Screening Reveals ALDH3A1 as a Lung Cancer Therapy Target | ACS Chem. Biol., 2018 Jul | Antibody | TA501105S |
| ALDH3B1 | Integrated proteomics and metabolomics analysis of lumbar in a rat model of osteoporosis treated with Gushukang capsules | BMC Complementary Medicine and Therapies, 2022 Dec | Antibody | TA323583 |
| ALDOA | Proteomic profiling of osteosarcoma cells identifies ALDOA and SULT1A3 as negative survival markers of human osteosarcoma | Mol. Carcinog., 2014 Sep | Antibody | AP08214PU-N |
| ALDOB | Proteomic profiling of the effect of metabolic acidosis on the apical membrane of the proximal convoluted tubule | Am. J. Physiol. Renal Physiol., 2012 Feb | Antibody | AP01402PU-N |
| ALK | Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing | Journal of clinical pathology, 2021 Apr | Antibody | UM800118 |
| ALK | Effect of hnRNPA2/B1 on the proliferation and apoptosis of glioma U251 cells via the regulation of AKT and STAT3 pathways | Biosci. Rep., 2020 Jul | Antibody | UM800118 |
| ALK | Effect of hnRNPA2/B1 on the proliferation and apoptosis of glioma U251 cells via the regulation of AKT and STAT3 pathways | Biosci. Rep., 2020 Jul | Antibody | TA800712 |
| ALK | Novel role for the Golgi membrane protein TMEM165 in control of migration and invasion for breast carcinoma | Oncotarget, 2020 Jul | Antibody | UM800118 |
| ALK | Novel role for the Golgi membrane protein TMEM165 in control of migration and invasion for breast carcinoma | Oncotarget, 2020 Jul | Antibody | TA800712 |
| ALK | Genes adapt to outsmart gene-targeting strategies in mutant mouse strains by skipping exons to reinitiate transcription and translation | Genome Biol., 2020 Jul | Antibody | UM800118 |
| ALK | Genes adapt to outsmart gene-targeting strategies in mutant mouse strains by skipping exons to reinitiate transcription and translation | Genome Biol., 2020 Jul | Antibody | TA800712 |
| ALK | Cerebellar Morphology and Behavioral Profiles in Mice Lacking Heparan Sulfate Ndst Gene Function | J Dev Biol, 2020 Jul | Antibody | TA801287 |
| ALK | Cerebellar Morphology and Behavioral Profiles in Mice Lacking Heparan Sulfate Ndst Gene Function | J Dev Biol, 2020 Jul | Antibody | TA800712 |
| ALK | Gene rearrangements in consecutive series of pediatric inflammatory myofibroblastic tumors | Pediatr Blood Cancer, 2020 Feb | Antibody | UM800118 |
| ALK | Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: A unique case from an older patient without clinical evidence of sickle cell trait | Pathol. Res. Pract., 2019 Sep | Antibody | TA800712 |
| ALK | ALK testing methods: Is there a winner or loser? | Expert Rev Anticancer Ther, 2018 Dec | Antibody | UM800118 |
| ALK | A Novel EML6-ALK FBXO11-ALK Double Fusion Variant in Lung Adenocarcinoma and Response to Crizotinib | J Thorac Oncol, 2018 Nov | Antibody | UM800118 |
| ALK | ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients | PGPM, 2018 Sep | Antibody | UM800118 |
| ALK | A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy | Oncotarget, 2018 Apr | Antibody | UM800118 |
| ALK | Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma | Oncol Lett, 2018 Apr | Antibody | TA801287S |
| ALK | Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma | Oncol Lett, 2018 Apr | Antibody | TA801287 |
| ALK | Anaplastic lymphoma kinase immunohistochemistry in lung adenocarcinomas: Evaluation of performance of standard manual method using D5F3 antibody | Indian J Cancer, 2017 Dec | Antibody | TA801287 |
| ALK | Anaplastic lymphoma kinase immunohistochemistry in lung adenocarcinomas: Evaluation of performance of standard manual method using D5F3 antibody | Indian J Cancer, 2017 Dec | Antibody | TA801287S |
| ALK | Worse disease-free, tumor-specific, and overall survival in surgically-resected lung adenocarcinoma patients with ALK rearrangement | Oncotarget, 2017 Oct | Antibody | TA800712 |
| ALK | Worse disease-free, tumor-specific, and overall survival in surgically-resected lung adenocarcinoma patients with ALK rearrangement | Oncotarget, 2017 Oct | Antibody | UM800118 |
| ALK | Worse disease-free, tumor-specific, and overall survival in surgically-resected lung adenocarcinoma patients with ALK rearrangement | Oncotarget, 2017 Oct | Antibody | TA800712S |
| ALK | ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice | Cancers (Basel) 2017, 2017 Aug | Antibody | UM800118 |
| ALK | Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society | Arch. Pathol. Lab. Med., 2017 Jul | Antibody | UM800118 |
| ALK | ALK evaluation in the world of multiplex testing: Network Genomic Medicine (NGM): the Cologne model for implementing personalised oncology | Ann. Oncol., 2016 Sep | Antibody | UM800118 |
| ALK | Antibody 1A4 with routine immunohistochemistry demonstrates high sensitivity for ALK rearrangement screening of Chinese lung adenocarcinoma patients: A single-center large-scale study | Lung Cancer, 2016 May | Antibody | UM800118 |
| ALK | ALK-Testung beim nicht-kleinzelligen Lungenkarzinom (NSCLC): Immunhistochemie (IHC) und/oder Fluoreszenz-in-situ-Hybridisierung (FISH)? | Pneumologie, 2016 Mar | Antibody | UM800118 |
| ALK | Stellungnahme der DGP und der AG Thorakale Onkologie der AG Onkologie/Deutsche Krebsgesellschaft e. V. zur ALK-Testung beim NSCLC | Der Pathologe, 2016 Mar | Antibody | UM800118 |
| ALK | Brief Report: Reliability assurance of EML4-ALK rearrangement detection in non-small cell lung cancer: the results of a proficiency testing in China | J Thorac Oncol, 2016 Mar | Antibody | UM800118 |
| ALK | A new, highly sensitive ALK antibody improves the screening of rearranged-ALK by IHC | AACR 2016 Abstract, 2016 Jan | Antibody | UM800118 |
| ALK | NordiQC Immunohistochemistry Quality Control Run 45 2015 on Lung Anaplastic Lymphoma Kinase (Lu-ALK) | NordiQC assessment Run 45 on ALK, 2015 Oct | Antibody | UM800118 |
Germany
Japan
United Kingdom
China